DuPont has signed an agreement to acquire the Memcor business - including ultrafiltration and membrane biofiltration technologies - from Evoqua Water Technologies Corp.
The transaction is expected to close by the end of 2019, subject to customary closing conditions and regulatory approvals.
“Our strategic intent for the water solutions business is to have a robust portfolio of technologies so that our talented global organization can leverage a broad range of solutions to solve our customers’ most pressing challenges,” said Marc Doyle, DuPont CEO.
“Recently, we announced the intended acquisition of BASF’s ultrafiltration membrane business.
“This second announcement reinforces our commitment to invest in specialty solutions aligned with high growth, attractive end markets where our continued innovation and customer relationships add value.”
The Evoqua ultrafiltration and membrane biofiltration technologies add to DuPont’s portfolio of water purification and separation capabilities, including ultrafiltration, reverse osmosis, and ion exchange resins.
Together with the intended acquisition of BASF’s ultrafiltration business, which is also expected to close by the end of the year subject to customary closing conditions and regulatory approvals, DuPont will be positioned to provide the products, technology and geographic diversification needed to meet current and future demand.
“DuPont and Evoqua have enjoyed a mutually beneficial long-standing business relationship, and this transaction further complements both companies’ strengths to focus more effectively on what each does best,” said HP Nanda, global VP and general manager for DuPont Water Solutions.
“The addition of Evoqua’s ultrafiltration portfolio opens DuPont Water Solutions to additional market spaces including membrane bioreactors, submerged and pressurised ultrafiltration systems bringing more choice and opportunity for customers.”